Relevance of the results of the Women's Health Initiative on the prescription of hormone therapy in Spain

Climacteric

Volumn 8, Issue 1, 2005, Pages 36-48

  Neyro, J L ^a   Cancelo, M J ^b   Quereda, F ^c   Palacios, S ^d,e  

^a HOSPITAL DE CRUCES   (Spain)

^b Pharmacy Service   (Spain)

^c HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^d Palacios Gynecology Institute   (Spain)

^e AEEMPalacio de Miraflores   (Spain)

Author keywords

After WHI; Hormone therapy; Menopause; Postmenopausal women; Women's health initiative

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ESTROGEN; GESTAGEN; RALOXIFENE; TIBOLONE; VITAMIN D;

BREAST CANCER; CANCER RISK; CARDIOVASCULAR RISK; DEEP VEIN THROMBOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HORMONE SUBSTITUTION; HUMAN; INTERVIEW; MENOPAUSAL SYNDROME; PHYSICIAN ATTITUDE; POSTMENOPAUSE OSTEOPOROSIS; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SPAIN;

ATTITUDE OF HEALTH PERSONNEL; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; GYNECOLOGY; HUMANS; MALE; MENOPAUSE; QUESTIONNAIRES; SPAIN; WOMEN'S HEALTH;

EID: 18744389128     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/13697130500062662     Document Type: Review

References (19)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. J Am Med Assoc 2002;288:321-33
2. Palacios S, Calaf J, Cano A, Parrilla JJ; Spanish Menopause Society (AEEM). Relevant results of the WHI study for the management of the menopause in Spain. Maturitas 2003;44:83-6
3. Lemay A. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice. J Obstet Gynaecol Can 2002;24:711-15
4. Speroff L. HT. A clinician demurs. Fertil Steril 2003;80(Suppl 4):15-18
5. McDonough PG. The randomized world is not without its imperfections: reflections on the Women's Health Initiative Study. Fertil Steril 2002;78:951-6
6. Vickers M, Meade T, Darbyshire J. WISDOM: history and early demise - was it inevitable? Climacteric 2002;5:317-25
7. Machens K, Schmidt-Gollwitzer K. Issues to debate on the Women's Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma? Hum Reprod 2003;18:1992-9
8. Burger H. Hormone replacement therapy in the post-Women's Health Initiative era. Report on a meeting held in Funchal, Madeira, February 24-25, 2003. Climacteric 2003;6(Suppl 1):11-36
9. Vinker S, Kaplan B, Yaphe J, et al. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel. Climacteric 2003;6:75-80
10. Taechakraichana N, Wilawan K, Wipatavit V, et al. Hormone replacement therapy: attitude and acceptance of Bangkokian women. J Med Assoc Thai 2003;86(Suppl 2):S385-98
11. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360:942-4
12. Kaplan B, Aschkenazi-Steinberg S, Yogev Y, Nahum R, Sulkes J, Phisher M. Gynecologists' trends and attitudes toward prescribing hormone replacement therapy during menopause. Menopause 2002;9:354-9
13. Elinson L, Cohen MM, Elmslie T. Hormone replacement therapy: a survey of Ontario physicians' prescribing practices. Can Med Assoc J 1999;161:695-8
14. Kaplan B, Rabinerson D, Yogev Y, Bar-Hava I, Bar J, Orvieto R. A survey of physicians' attitude and approach to hormone replacement therapy during menopause. Clin Exp Obstet Gynecol 2002;29:31-3
15. Levy BT, Ritchie JM, Smith E, Gray T, Zhang W. Physician specialty is significantly associated with hormone replacement therapy use. Obstet Gynecol 2003;101:114-22
16. Blumel JE, Castelo-Branco C, Kerrigan N, et al. Influences of hormone replacement therapy on postmenopausal women's health perceptions. Menopause 2003;10:235-40
17. Scheid DC, Coleman MT, Hamm RM. Do perceptions of risk and quality of life affect use of hormone replacement therapy by postmenopausal women? J Am Board Fam Pract 2003;16:270-7
18. Jolleys JV, Olesen F. A comparative study of prescribing of hormone replacement therapy in USA and Europe. Maturitas 1996;23:47-53
19. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. J Am Med Assoc 2004;291:1701-12